von Stefanie Simons | Okt 2, 2019
DGN Kongress - StuttgartSeptember 26th, 2019 Learn more Prof. Dieter Willbold participated at the DGN Kongress in Stuttgart.He gave a talk on the 26th September at 09.10 am.Content: Targeting Alzheimer´s disease with the first anti-prionic compound: PRI-002 proved...
von Stefanie Simons | Jul 5, 2019
AAIC - Los AngelesJuly 14th – 18th, 2019 Learn more Priavoid will participate at the AAIC 2019 in Los Angeles. News & Events: BIO.NRW MEDICA-FORUM3. Dezember 2019 DGN Kongress 20192. Oktober 2019 Seed Investment6. Mai 2019 CEOs of Priavoid3. Mai 2019 AD/PD...
von Stefanie Simons | Jun 3, 2019
Keystone SymposiumJune 18th, 2019 – Keystone, CO, USA Learn more Dieter Willbold will present PRI-002 at the Keystone Symposium “Neurodegenerative Diseases: New Insights and Therapeutic Opportunities (Z2) in Keystone, CO, USA. News & Events: BIO.NRW...
von Dagmar jürgens | Mai 6, 2019
Neuro4D Conference 2019May 14th – 15th, 2019 – Mainz, Germany Learn more May 13th, 2019: Dieter Willbold will present PRI-002 at the Neuro4D Confernce in Mainz, Germany. May 14th, 2019: Antje Willuweit will present PRI-003 at the Neuro4D Conference in...
von Dagmar jürgens | Mrz 26, 2019
AD/PD 2019 March 26th – 31st, 2019 – Lisbon Learn more 29th March 2019: Dieter Willbold presented PRI-002 on the AD/PD 2019 in Lisbon.For further information please click the learn more button above. News & Events: DGN Kongress 20192. Oktober 2019 AAIC...
Neueste Kommentare